NCT04603391View on ClinicalTrials.gov

Cannabidiol and CES1 Interactions in Healthy Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Drug Interaction
Interventions
DRUG

dl-Methylphenidate plus Cannabidiol

Subjects will be administered one 10 mg tablet of dl-methylphenidate (Ritalin®) plus 7.5 mL Epidiolex® solution

DRUG

dl-Methylphenidate plus Cannabidiol Placebo solution

Subjects will be administered one 10 mg tablet of dl-methylphenidate (Ritalin®) plus 7.5 mL of Epidiolex® placebo solution

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

Consortium for Medical Marijuana Clinical Outcomes Research

OTHER

lead

University of Florida

OTHER

NCT04603391 - Cannabidiol and CES1 Interactions in Healthy Subjects | Biotech Hunter | Biotech Hunter